SG Americas Securities’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
SG Americas Securities's ATRC Position: Q2 2026 in Review
SG Americas Securities reduced its AtriCure (ATRC) stake by 63% in Q2 2026, selling an estimated $170K and leaving 3,601 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.
SG Americas Securities first reported a position in ATRC in Q1 2014 and has held it in 24 quarters since. The position peaked at $2.47M in Q3 2019. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- SG Americas Securities held 3,601 shares of AtriCure worth $101K as of Q2 2026.
- SG Americas Securities sold 6,026 AtriCure shares in Q2 2026, an estimated $170K.
- AtriCure made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3114 holding.
- SG Americas Securities first reported a position in AtriCure in Q1 2014 and has held it in 24 quarters since.
- SG Americas Securities's AtriCure position peaked at $2.47M in Q3 2019.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.